The Portuguese competition authority, known as AdC, has decided to conduct an in-depth investigation into the concentration operation Ccent/2026/29 involving Stemlab and Cordvida. This decision was made on September 7, 2026, by the Board of Directors of the authority.

The investigation was prompted by significant concerns regarding the compatibility of the merger with the relevant market criteria as outlined in the Competition Law. The authority referenced specific articles from the law that raised doubts about the merger's impact on competition.

As part of the investigation, the AdC will analyze various elements related to the merger to determine whether it meets the necessary legal standards for approval.